JavaScript Required

JavaScript is required to use content on this page. Please enable JavaScript in your browser.

Maryland Prescription Drug Affordability Board

The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

01
11

Prescription Drug Affordability Board Meeting: Monday, May 18, 2026 at 2:00PM

Prescription Drug Affordability Board Meeting: Monday, May 18, 2026 at 2:00PM

Join the Prescription Drug Affordability Board's Mailing List

Join the Prescription Drug Affordability Board's Mailing List

Announcements

UPCOMING MEETING: Prescription Drug Affordability Board, Monday, May 18, 2026 at 2:00PM. Meeting information can be found here.

WRITTEN COMMENT REQUEST: Draft Proposed Regulations for Comment (Posted: 5/1/2026): The PDAB is soliciting comments on proposed revisions to COMAR 14.01.04 Cost Review Study Process. Information can be found here.
Data Request: The Maryland Prescription Drug Affordability Board may require covered entities and 340B manufacturers to report information as necessary to complete a study on the implementation, impact, and finances of the 340B program in Maryland, as outlined in 2024 Md. Laws, Chap. 962 (HB 1056). Please see the Data request webpage for more information.

Join the PDAB Mailing List here.

Get Involved

Public Meetings

Board Meetings

Stakeholder Council

Cost Review Study Process

Board Selected Drugs

Report an Affordability Issue

How We Work

Regulations

Fee Assessment Instructions

Quick Links

Reports

News and
Announcements

Contact Us